WallStreetZenWallStreetZen

NASDAQ: DERM
Journey Medical Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DERM

Based on 3 analysts offering 12 month price targets for Journey Medical Corp

Min Forecast
$12.00+37.61%
Avg Forecast
$12.67+45.26%
Max Forecast
$13.00+49.08%

Should I buy or sell DERM stock?

Based on 3 analysts offering ratings for Journey Medical Corp.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although DERM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates DERM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their DERM stock forecasts and price targets.

DERM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-25
lockedlocked$00.00+00.00%2025-08-13
lockedlocked$00.00+00.00%2025-07-30

1 of 1

Forecast return on equity

Is DERM forecast to generate an efficient return?

Company
136.27%
Industry
218.19%
Market
361.52%
DERM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DERM forecast to generate an efficient return on assets?

Company
41.42%
Industry
118.29%
DERM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DERM earnings per share forecast

What is DERM's earnings per share in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.26
Avg 2 year Forecast
$1.30

DERM revenue forecast

What is DERM's revenue in the next 2 years based on estimates from 6 analysts?

Avg 1 year Forecast
$102.8M+73%
Avg 2 year Forecast
$157.2M+164.58%
DERM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DERM revenue growth forecast

How is DERM forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
73%
Industry
3,774.99%
Market
1,611.96%
DERM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DERM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DERM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
DERM$8.72$12.67+45.26%Strong Buy
ACB$4.42N/AN/A
OGI$1.65N/AN/A
TKNO$3.16N/AN/A
EOLS$4.95$18.20+267.68%Buy
View Top Pharmaceutical Stocks

Journey Medical Stock Forecast FAQ

Is Journey Medical Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: DERM) stock is to Strong Buy DERM stock.

Out of 3 analysts, 2 (66.67%) are recommending DERM as a Strong Buy, 1 (33.33%) are recommending DERM as a Buy, 0 (0%) are recommending DERM as a Hold, 0 (0%) are recommending DERM as a Sell, and 0 (0%) are recommending DERM as a Strong Sell.

If you're new to stock investing, here's how to buy Journey Medical stock.

What is DERM's earnings growth forecast for 2026-2027?

(NASDAQ: DERM) Journey Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 40,728.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,309.49%.

Journey Medical's earnings in 2026 is -$8,663,000.On average, 6 Wall Street analysts forecast DERM's earnings for 2026 to be $6,990,209, with the lowest DERM earnings forecast at $4,520,842, and the highest DERM earnings forecast at $10,257,372.

In 2027, DERM is forecast to generate $35,290,244 in earnings, with the lowest earnings forecast at $31,114,029 and the highest earnings forecast at $39,319,926.

What is DERM's revenue growth forecast for 2026-2027?

(NASDAQ: DERM) Journey Medical's forecast annual revenue growth rate of 73% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,774.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,611.96%.

Journey Medical's revenue in 2026 is $59,399,000.On average, 6 Wall Street analysts forecast DERM's revenue for 2026 to be $2,788,485,598, with the lowest DERM revenue forecast at $2,616,769,591, and the highest DERM revenue forecast at $2,995,532,553.

In 2027, DERM is forecast to generate $4,264,678,830 in revenue, with the lowest revenue forecast at $3,961,299,412 and the highest revenue forecast at $4,536,037,880.

What is DERM's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: DERM) forecast ROA is 41.42%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 118.29%.

What is DERM's Price Target?

According to 3 Wall Street analysts that have issued a 1 year DERM price target, the average DERM price target is $12.67, with the highest DERM stock price forecast at $13.00 and the lowest DERM stock price forecast at $12.00.

On average, Wall Street analysts predict that Journey Medical's share price could reach $12.67 by Aug 25, 2026. The average Journey Medical stock price prediction forecasts a potential upside of 45.26% from the current DERM share price of $8.72.

What is DERM's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: DERM) Journey Medical's current Earnings Per Share (EPS) is -$0.35. On average, analysts forecast that DERM's EPS will be $0.26 for 2026, with the lowest EPS forecast at $0.17, and the highest EPS forecast at $0.38. In 2027, DERM's EPS is forecast to hit $1.30 (min: $1.15, max: $1.45).

What is DERM's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: DERM) forecast ROE is 136.27%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.